P. Mohr

发表

THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE UNITED STATES

P. Mohr, J. Feldman, J. Dunbar, 2000, International Journal of Technology Assessment in Health Care.

Methodological recommendations for comparative research on the treatment of chronic wounds.

P. Mohr, S. Sonnad, S. Tunis, 2013, Journal of wound care.

Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020.

P. Mohr, D. Messner, A. Towse, 2015, Journal of comparative effectiveness research.

Medical and Pharmacy Coverage Decision Making at the Population Level

P. Mohr, S. Tunis, 2014, Journal of managed care & specialty pharmacy.

Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers.

C. Mullins, P. Mohr, S. Sonnad, 2013, Contemporary clinical trials.

Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores

P. Mohr, L. Lenert, M. Rupnow, 2004, Schizophrenia Research.

Improvement in Kidney Function: A Real Occurrence

G. Eknoyan, S. Rajagopalan, T. Hostetter, 2012 .

The case for dialy dialysis: Its impact on costs and quality of life

P. Mohr, P. Neumann, G. Ting, 2001 .

A translation table for patient-centered comparative effectiveness research: guidance to improve the value of research for clinical and health policy decision-making.

P. Mohr, R. Gliklich, D. Messner, 2012, Journal of Comparative Effectiveness Research.

Improving the Quality and Efficiency of the Medicare Program Through Coverage Policy Timely Analysis of Immediate Health Policy Issues August 2011

P. Mohr, R. Berenson, S. Tunis, 2011 .

A business model approach to quotidian hemodialysis.

P. Mohr, P. McFarlane, A. Kroeker, 2004, Contributions to nephrology.

The economics of daily dialysis.

P. Mohr, 2001, Advances in renal replacement therapy.

The quality of life and economic implications of daily dialysis.

P. Mohr, P. Neumann, S. J. Franco, 1999, Policy analysis brief. H series.

Access with Evidence Development

P. Mohr, S. Tunis, 2012, PharmacoEconomics.

Three Perspectives on the Impact of Comparative Effectiveness Research on Decision Making

P. Mohr, D. Brixner, R. Dubois, 2012, Journal of Managed Care Pharmacy : JMCP.

Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis.

P. Mohr, J. Polinski, L. Johnson, 2009, Arthritis and rheumatism.

The future of comparative effectiveness and relative efficacy of drugs: an international perspective.

P. Mohr, D. Messner, A. Towse, 2015, Journal of comparative effectiveness research.

Using survey data to estimate prescription drug costs.

P. Mohr, C. Schur, M. Berk, 1990, Health affairs.

Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.

S. Cummings, P. Mohr, J. Singh, 2012, Contemporary clinical trials.

Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.

Andrew Briggs, Louis P Garrison, Adrian Towse, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Christopher T. Chan, G. Eknoyan, M. Rocco, 2011, Kidney international.

Digital health & low-value care.

P. Mohr, C. Petersen, C. Sarkisian, 2021, Healthcare.

Incorporating stakeholder perspectives in developing a translation table framework for comparative effectiveness research.

Michelle B. Leavy, N. Dreyer, P. Mohr, 2012, Journal of comparative effectiveness research.

The heterogeneity of schizophrenia in disease states

R. Conley, P. Mohr, J. Feldman, 2004, Schizophrenia Research.

The case for daily dialysis: its impact on costs and quality of life.

P. Mohr, P. Neumann, S. J. Franco, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Looking at CER from Medicare's perspective.

P. Mohr, 2012, Journal of managed care pharmacy : JMCP.

Implications for rural hospitals of the Medicare outpatient prospective payment proposed rule.

P. Mohr, S. J. Franco, 1999, Policy analysis brief. W series.

How many small rural hospitals meet the requirements of critical access hospital designation?

P. Mohr, B. Blanchfield, S. J. Franco, 1999, Policy analysis brief. W series.

Vulnerability of Rural Hospitals to Medicare Outpatient Payment Reform

P. Mohr, B. Blanchfield, W. Evans, 1999, Health care financing review.

PAYER PERSPECTIVES ON FUTURE ACCEPTABILITY OF COMPARATIVE EFFECTIVENESS AND RELATIVE EFFECTIVENESS RESEARCH

E. Hawe, P. Mohr, R. Moloney, 2015, International Journal of Technology Assessment in Health Care.